7/1013 sources · 7 publishersUpdated Nov 20, 21:00 UTC
TD Cowen upgrades UnitedHealth to Buy and raises price target to $455
TD Cowen upgraded UnitedHealth Group (UNH) from Hold to Buy and lifted its price target to $455, up from $402. The broker expects mid‑to‑high‑teens adjusted EPS growth through 2028, with EPS projected at $23.57 in 2027 and $27.61 in 2028. The upgrade follows a Q3 2026 earnings beat and a modest 0.41% YoY decline in revenue to $112.7 billion.
Why it matters
The higher target implies roughly 16.5‑times 2028 EPS and suggests upside of about 37% from the current price, according to TD Cowen. Investors will watch whether the projected EPS growth materialises as the firm improves Medicare Advantage margins and Optum Health performance.
Key facts
- 1TD Cowen raised UnitedHealth's price target to $455 from $402. investing.com
- 2The upgrade moves UnitedHealth to a Buy rating from Hold. investing.com
- 3TD Cowen forecasts mid‑to‑high‑teens adjusted EPS growth through 2028. investing.com
- 4TD Cowen projects adjusted EPS of $23.57 for 2027 and $27.61 for 2028. investing.com
- 5UnitedHealth reported Q3 2026 revenue of $112.7 billion, down 0.41% YoY. quiverquant.com
- 6Analyst Ryan Langston named UnitedHealth the 2027 Best Idea. investing.com
Summary written by AlphAI AI Desk from 13 of 13 sources. Not investment advice. Figures are as stated by the linked sources.